A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1% Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.

Recruitment & Eligibility

Status: ot Recruiting

Sex: All

Target Recruitment: 123

Inclusion Criteria

•Male or female patients, age = 18 years
•Planned to undergo cataract surgery on one eye by phaco-emulsification with posterior chamber intraocular lens and using topical anaesthesia.
•Pre-operative flare = 15 ph/ms, measured with the laser flare meter (LFM) without pharmacological pupil dilation, within the 2 months preoperatively
•Subject must read, understand and signed the Inform Consent Form.
•Women of childbearing potential, must have negative urine pregnancy test at baseline.
•Subject willing to comply with all treatment and follow-up procedures.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Inflammatory and/or infectious pathology of the eye and its adnexa
•History of post-operative intraocular infection in the fellow eye
•Glaucoma in the study eye
•Post-traumatic cataract in the study eye
•Exfoliative syndrome
•Diabetes
•History of uveitis
•Any progressive pathology requiring the use of topical or systemic anti-inflammatory or anti-infectious agents
•Immunodepression
•History of intolerance to the tested drugs and to any NSAI drug
•Monocular patients (for any other reason than cataract)
•Patients treated with local or systemic anti-inflammatory drugs within 10 days prior to inclusion
•In the case of cataract surgery on the 2nd eye, if the subject was already included inthe study for the 1st eye, teh 2nd eye cannot be considered another study eye;
•Pregnant and lactating women
•Active peptic ulcer
•Severe hepatocellular or renal impairment
•Subject who take acetylsalicylic acid at doses >100mg and cannot discontinue usage during the study.
•Asthma linked to acetylsalicylic acid or NSAI
•Surgery planned during the study other than cataract surgery or cataract surgery on the fellow eye.
•Subjects who have surgery planned to occur during the course of the study other than cataract surgery on the study eye or cataract surgery on the fellow eye. If surgery is planned to occur for the fellow eye before Visit 5 (Day 30 ± 3 days) is completed, the subject must be excluded.
• Women sexually active and who do not fall into one of the following categories :
Post menopausal / Surgically sterile / Using one birth control methods throughout the duration of the study (Intrauterine device > 14 days - Barrier method, diaphram or condom, with spermicide < 14 days- hormonal contraception, same dose and same formulation for at least 6 months) .

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method

Secondary Outcome Measures

Name	Time	Method

Related Trials